Crossref
Immunosuppressive Agents and Their Role in Managing Immunotherapy Toxicities in Melanoma
Clinical Skin Cancer · 2017-12 · 2 (1-2) · 18-23
DOI: 10.1016/j.clsc.2017.07.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Skin Cancer, 2017-12. Verfasst von Romaana Mir und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mir, R., Shaw, H. M., & Nathan, P. D. (2017). Immunosuppressive Agents and Their Role in Managing Immunotherapy Toxicities in Melanoma. Clinical Skin Cancer, 2(1-2), 18-23. https://doi.org/10.1016/j.clsc.2017.07.001
Vancouver
Mir R, Shaw HM, Nathan PD. Immunosuppressive Agents and Their Role in Managing Immunotherapy Toxicities in Melanoma. Clinical Skin Cancer. 2017;2(1-2):18-23. doi:10.1016/j.clsc.2017.07.001
BibTeX
@article{Mir2017,
author = {Mir, Romaana and Shaw, Heather M. and Nathan, Paul D.},
title = {Immunosuppressive Agents and Their Role in Managing Immunotherapy Toxicities in Melanoma},
journal = {Clinical Skin Cancer},
year = {2017},
volume = {2},
number = {1-2},
pages = {18--23},
doi = {10.1016/j.clsc.2017.07.001}
}
EUVIMED